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DOI: 10.1039/c0lc00537aSpecific-purpose microfluidic devices have had considerable impact on the biological and chemical
sciences, yet their use has largely remained limited to specialized laboratories. Here we present
a general-purpose software-programmable microfluidic device which is capable of performing
a multitude of low- and high-level functions without requiring any hardware modifications. To
demonstrate the applicability and modularity of the device we implemented a variety of applications
such as a microfluidic display, fluid metering and active mixing, surface immunoassays, and cell culture.
We believe that analogously to personal computers, programmable, general-purpose devices will
increase the accessibility and advance the pervasiveness of microfluidic technology.Microfluidic technology has progressed considerably in the last
decade, through the development of simple fabrication methods
such as soft lithography,1 the implementation of micro-
mechanical valves,2,3 and the development of monolithic inte-
gration techniques.4 It is now possible to robustly fabricate
microfluidic devices containing thousands of components,
enabling the implementation of complex high-throughput
assays.5,6 These fluid handling capabilities combined with its
considerable economies of scale have made microfluidic tech-
nology essential in many areas including cell culture,7–12 protein
biochemistry,5,13,14 protein crystallization15,16 and chemistry.17
The developments in microfluidic integration have frequently
been compared to the evolution of computer hardware.18 Before
the advent of the integrated circuit, the first electronic computers,
such as the ENIAC,19 needed to be physically re-wired before
each new computing task. Analogously, 60 years later, in order
to apply a microfluidic device to a new task, a new channel layout
needs to be designed and physically implemented. This is a long
and expensive process that requires expert knowledge of micro-
fabrication and fluid physics.20 The development of program-
mable, general-purpose computing machines transformed
computers into ubiquitous information-processing tools.21 It
follows that the development of a fully software-programmable
microfluidic device (PMD) could prove equally crucial for
microfluidic technology. PMDs would allow the establishment of
generic hardware elements whose function could be configured
through an additional layer of software abstraction. With
a generic architecture users could focus on adapting, developing,
and disseminating software tools for their applications.School of Engineering, Institute of Bioengineering, Ecole Polytechnique
Federale de Lausanne, 1015, Switzerland. E-mail: sebastian.maerkl@epfl.
ch; Fax: +41 2169 37830; Tel: +41 2169 37835
† Electronic supplementary information (ESI) available: Fabrication and
experimental details; video sequences. See DOI: 10.1039/c0lc00537a
1612 | Lab Chip, 2011, 11, 1612–1619Furthermore, implementing numerous applications in a generic
architecture would greatly decrease development costs.
Programability and versatility have been successfully achieved
in electrowetting-on-dielectric microfluidic devices.22,23 However,
integration and miniaturization in these devices is still limited as
systems commonly contain only tens of active components and
the unit volumes handled often fall in the microlitre range.
Nevertheless, electrowetting-on-dielectric microfluidic devices
have recently been applied to biologically relevant problems such
as cell culturing.24 Progress towards programmability has also
been made with valve-based systems,25,26 although current
implementations tend to be limited either in their versatility, size,
or integration. Jensen et al. presented a device featuring 64
individually addressable micromechanical valves, but the size
and volume of each element is relatively large with a diameter of
1.64 mm and a volume of 120 nl.25 Furthermore, each of the 64
micromechanical valves has to be controlled separately by one of
64 off-chip solenoid valves. The device designed by Chang et al.,
on the other hand, features elements with considerably smaller
volumes of 400 pl and a size of only a few hundred microns.26
Furthermore, electrostatic actuation of their functional elements
completely eliminates the need for off-chip control elements.
Unfortunately, Chang’s device only featured 7 of these electro-
statically-driven control elements, severely limiting its versatility.
Finally, both these examples combine the chamber units and
control valves into a single functional element, which reduces the
malleability of the network and the total number of functional
configurations.
In this work, we present a broadly applicable, fully software-
programmable microfluidic device based on microfluidic large-
scale integration (MLSI).4 Our device features 64  300 pl nodes
controlled by 114 individually addressable valves. Each of these
nodes is surrounded by up to four valves allowing variable
interconnections and the implementation of arbitrary channel
structures. We integrated a microfluidic multiplexer to controlThis journal is ª The Royal Society of Chemistry 2011
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View Onlinethe array of valves, which significantly reduced the number of
necessary off-chip control elements to 15. Including the fluid
input control, the device contains a total of 918 micromechanical
valves controlled by 21 external solenoid valves. To demonstrate
the potential of this architecture we implemented various
programs to perform tasks that previously required specialized
devices, such as a microfluidic display,4 active mixing and micro-
formulation,15 patterned surface immunoassays27 and cell
culture.7
1. Experimental
1.1. Microfluidic fabrication
Devices were molded in poly(dimethyl siloxane) (PDMS) (RTV
615, General Electric) following a fabrication protocol adapted
from that described previously by Hansen et al.15 In order to
individually route each core valve while maintaining adequate
channel and valve dimensions, we placed the routing channels
and the valves on two separate layers interconnected through
microfluidic vias.28,29 Vias were formed by spin coating a PDMS
film thinner than the combined height of the SU8 features from
which valves and vias were molded. This resulted in a perforated
membrane to which the routing layer was aligned. After bonding,
this combined stack was aligned to the PDMS layer containing
the flow and multiplexer channels. We found this method to be
robust and efficient as no additional handling steps are required.
A full description of the layer stack and fabrication details can be
found in the ESI.†
1.2. Device operation
Pneumatic valves were operated by solenoid valves (Pneumadyne
Inc.) connected to a PC computer through a custom-made
control box. Typical operation pressures were 5, 25 and 55 psi
for the flow, control and multiplexer layers, respectively. The
software used to address the solenoid elements was written in
Visual Basic. The programs were based on a series of pneumatic
operations aimed at addressing each core valve (Fig. 2a–e).
Complex protocols were created by scripting sequential actua-
tion of core valves giving rise to specific geometries on the PMD
to shunt fluid according to the assay requirements.
1.3. Surface immunoassays
Antibody patterns were created on the glass surface of the device
by sequentially flowing a blocking solution of 2% bovine serum
albumin (Sigma) in water and antibody solutions through
selected nodes. The proteins rapidly adsorbed to the glass surface
without the need of additional coupling chemistry. The anti-
bodies used were anti-GST Alexa-647 and anti-GFP (Abcam),
diluted to 1 : 100 in phosphate buffered saline buffer (PBS)
before use. eGFP (BioVision) was diluted to 1 : 500 in 2% BSA
dH2O. BSA blocking, antibody deposition and eGFP deposition
were performed by flowing the solution of interest for 10 min
followed by a 5 min rinse with PBS. In the construction of the
A-GST pattern longer deposition times were used for complex
channel geometries to compensate for their higher resistance. In
the eGFP immunoassay, BSA was flowed through the channels
where antibody was deposited before flowing eGFP to preventThis journal is ª The Royal Society of Chemistry 2011any non-specific binding. After flowing GFP, BSA was flowed
through the same rows to remove any non-specifically bound
protein.1.4. Cell culture
The yeast strains used were wild type (BY4741, MATa his3D1
leu2D0 met15D0 ura3D0) and a mutant expressing mCherry
under the control of the PHO5 promoter (BY4741;
trp1D::PPHO5-mCherry-Kan). Liquid cultures were prepared by
inoculating samples of 3 ml synthetically defined medium
(Sigma) that were incubated overnight and diluted 1 : 2 in fresh
medium 4 h before use. Standard culture medium contained
10 mM inorganic phosphate, whereas induction medium con-
tained no inorganic phosphate. On- and off-chip culturing was
conducted at 30 C.2. Device architecture and operation
The PMD’s generic architecture consists of a network of inter-
secting channels controlled by an array of 114 independently
addressable elastomeric valves (Fig. 1). We used a 7-bit binary
multiplexer and latching4 to independently control the 114 core
valves with only 15 inputs (Fig. 2a–e). When all valves are
pressurized, each of the 64 network nodes becomes a 300 pl
reaction vessel (Fig. 1c). Opening a sequence of valves connecting
nodes between the entrance and exit creates a route through the
network into which flow can be directed. The input–output tree
controls which solutions are introduced at any given time
(Fig. 1a). Due to complete control over the connectivity of the
network nodes, there are no restrictions in the geometry of that
route and complex channels can be implemented within seconds
and in real-time (Fig. 2f, Video S1†).
We observed that when closing core valves fluid was occa-
sionally displaced between nodes in an uncontrolled manner.
Fluid displacement is inherent to this type of zero dead-volume
valve, but in a closed network design such as ours it can induce
cross-talk between nodes. We designed and implemented fluidic
capacitors to accommodate the fluid displaced when closing core
valves (Fig. 1c, Fig. S2†). The capacitors consisted of square
spaces located above each node into which the PDMS membrane
could deflect. Fig. S2† contains a schematic of a node and the
corresponding capacitor when the adjacent core valves are either
open or closed. It also shows micrographs of two devices with
closed core valves after loading a red dye, and the elimination of
the cross-talk between nodes in the device containing capacitors.
Several critical parameters determine the usability of a PMD,
the speed of device reprogramming being one of the most
important aspects. In our device, the minimal time required to
actuate a core valve is below 100 ms. The shortest time to create
a route through the network amounts to 1.6 s and can extend to
several seconds, depending on the complexity of the path or the
number of core valves that need to be actuated to create the path.
A second critical parameter for the performance of our recon-
figurable platform is its durability. PDMS elastomeric valves
have been shown to withstand extended use without signs of
wear.2 Operating our devices at the speeds indicated did not lead
to performance reduction after running a display routine
continuously for more than 18 h or a cell culture program forLab Chip, 2011, 11, 1612–1619 | 1613
Fig. 1 Software-programmable microfluidic platform. (a) Photograph of the PMD outlining its constitutive modules. A channel network (blue) sits at
the center of a core valve array (red) controlled by a 7-bit microfludic multiplexer (green) and a master core input. A separate set of valves controls the
flow of liquid into the network. (b) Micrograph of the central channel network. Individually addressable valves surround each network node providing
full control over their connectivity. Routing channels access valves through microfluidic vias from a separate layer above. (c) Micrograph of a network
node. Each node constitutes a 300 pl vessel and consists of several core valves and a microfluidic capacitor.
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View Online24 h. In both cases the number of multiplexing and valve
actuating operations exceeded 105. Finally, a measure of the
flexibility of a reconfigurable platform is the number of unique
configurations it can achieve. In our case, without taking into
account the input module, these amount to 2114 or over 2  1034
states.
Our PMD represents a versatile and inexpensive microfluidic
platform capable of handling volumes as small as 300 pl, with
a total footprint of 20  30 mm and requiring 21 external
controls, 15 for multiplexing and 6 to control fluid input. Its
operation is simplified through a layer of abstraction making it
particularly suitable for use by a broad spectrum of scientists
with no microfluidic expertise. The following sections describe
the set of fluidic operations used to build up more complex
protocols as well as implementations of representative applica-
tions traditionally performed on specialized devices.3. Applications
3.1. Microfluidic display
To demonstrate the capabilities of our microfluidic device for
automated node addressing and compound loading, we wrote
a simple program that created dye patterns resembling letters. To
create each pattern, the program determined which nodes needed
to be ‘‘re-written‘‘ into a new state: red or white. The program
created a fluidic path from input to output to address each node.
Once the path was created, the correct solution—red dye or
water—was flown through the node until the contents of the1614 | Lab Chip, 2011, 11, 1612–1619node were completely replaced. Creating the fluidic path required
1.6 s for each node, whereas replacing the contents took 6 s and
an approximate volume of 80 nl. Iteratively repeating this
addressing and loading procedure yielded the intended pattern
that was stored for a given time before continuing with the next
one (Fig. 2g, Video S2†).
In addition to the wait times for valve actuation and fluid
loading, the only input the user must provide is the sequence of
letters to be displayed. We believe this example illustrates how
easily users can determine the location of compounds within the
network. Moreover, it also shows how the loading procedure
can be carried out in a few minutes, using only minute amounts
of the compounds of interest. Simple modification to the
software program could adopt this loading routine to almost
any basic microfluidic device functionality and more specialized
applications such as immunoassays as described in the next
section.
3.2. Surface immunoassays
Immunoassays constitute a fundamental tool in biological
research, and their miniaturization has received significant
attention.27,30 To illustrate how surface immunoassays could
easily be implemented in our reconfigurable platform we carried
out two separate experiments based on the dynamic channel
reconfiguration described above. In the first experiment, we used
sequential channel routing across the network to create a surface
pattern of a fluorescently labeled anti-GST (A-GST) antibody.
We achieved this by selectively flowing either BSA or anThis journal is ª The Royal Society of Chemistry 2011
Fig. 2 (a–e) Schematic diagram of the steps required to actuate core valves. All core valves are initially closed (a). To open a valve, the multiplexer is
addressed to allow flow through the corresponding control channel (b). The core input valve is depressurized allowing the selected valve to open (c).
Pressurizing the multiplexer stores the open state for the addressed valve (d), and allows re-pressurizing of the core input without modifying the state of
the core valves (e). (f) Controlled fluid delivery in the PMD. Opening the valves between the selected nodes creates a channel across the network into
which fluid can be directed. The channel was filled with red dye for visualization (Video S1†). (g) Micrographs showing red dye patterns generated
through sequential node addressing and loading displaying the letters LBNC (Video S2†). Scale bars are 500 mm.
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View Onlineantibody solution through complex fluidic paths. When flowed
through a channel, BSA deposited on the surface blocking the
posterior adsorption of the antibody and therefore generating
‘‘black’’ areas. Flowing the antibody solution over the areas that
were not exposed to BSA created the pattern later imaged with
fluorescence microscopy (Fig. 3a).
In the second experiment, we used a similar approach to
pattern two antibodies, the same fluorescently-labeled anti-GST
and a non-labeled anti-GFP (A-GFP) antibody. We patterned
these two antibodies in adjacent columns while all other areas of
the network were blocked with BSA. We then flowed eGFP
horizontally in alternating rows, which bound selectively to the
anti-GFP antibody (Fig. 3b–c).3.3. Micro-formulation
Microfluidic technology offers great advantages as a platform for
biochemistry and chemistry, such as throughput, accuracy, and
automation.15,17 Formulation in a microfluidic environment
requires higher-level functionalities such as accurate fluid
metering and efficient mixing. Our PMD is well suited for both,
since nodes can be used as loading units and core valves can be
used for active mixing using ring mixers.31
We implemented a variety of ring mixer geometries, involving
12, 10 or 4 nodes (Fig. 4). Video S3† shows an image sequence
were multiple ring mixers are implemented sequentially, using
them to actively mix a colored dye (Fe(SCN)3). We loadedThis journal is ª The Royal Society of Chemistry 2011a section of a 12-node ring with a dye solution that was actively
mixed with the contents of the remaining nodes (Fig. 4b).
Following this mixing, three 4-node rings were created at
different locations, resulting in three different final concentra-
tions of the dye (Fig. 4c). The capacity to create ring mixers at
any location within the network could be beneficial not only for
accurate formulation, but also for in situ compound dosing in
multistep reactions or cell culture. The software-interface
requires as input only the type and location of the mixer within
the network and the desired mixing time.
The required mixing time depends on the size of the ring and
varies between 30 s (4-node ring, Fig. 5b) and 150 s (12-node ring,
Fig. 5a). To measure the time required for mixing we measured
pixel intensity at a fixed position in the ring during an image
sequence of dye mixing. Using software implemented mixers
allowed us to dynamically program the peristaltic pump in our
12-node mixer to optimize mixing speeds (Fig. 5a). Mixing time
increased as the number of valves used for pumping decreased,
although mixing still occurred when only two valves where used.
Using one valve induced no appreciable peristaltic flow and the
speed of mixing was similar to that by diffusion only. Fig. 5b
shows mixing curves for a 4-node ring where four pumps were
used for mixing. Both curves were obtained measuring pixel
intensity at the same position, but for each of them either the top
or the bottom row were loaded with dye, inducing a 90 phase
shift in the mixing curve. The time required to homogenize the 4-
node ring was approximately 30 s.Lab Chip, 2011, 11, 1612–1619 | 1615
Fig. 3 (a) Fluorescence micrograph of an Alexa-647-labeled anti-GST pattern displaying the letters EPFL. Routing fluids across the network and
flowing either BSA or antibody, selected regions were either protected or labeled, creating the resulting pattern. (b) Fluorescence micrograph showing
a pattern of labeled anti-GST and eGFP. A-GST and A-GFP antibodies were deposited in parallel columns while the rest of the network was protected
with BSA. eGFP was flowed through alternative rows from right to left. The micrograph shows A-GST deposition throughout the entire column and
eGFP deposition exclusively at the intersection between the A-GFP column and the eGFP rows. Scale bars are 500 mm. (c) Quantification of the eGFP
immunoassay. Measurements of the fluorescence intensity at 530 nm for the nodes at the intersection between the eGFP rows and the anti-GFP, anti-
GST and BSA columns show selective eGFP deposition at selected locations. Each bar represents the average of three measurements and the error bars
show one standard deviation.
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View OnlineActive mixing combined with fluid metering can be used to
accurately formulate compositions in situ. Concentration gradi-
ents can easily be created by loading different quantities of
a reagent in a given ring size. We created an array of dye
concentrations by loading an increasing number of nodes with
dye in 3 separate 4-node rings (Video S4,† Fig. 5c–d). Absor-
bance values extracted from the micrographs for each final
concentration show good agreement with Lambert–Beer’s law
demonstrating the accuracy of the formulation (Fig. 5e).
In addition to using nodes as metering units, the PMD allows
peristaltic pumping to accurately dose compounds.15 We believe
that the ability to generate complex mixtures confers onto the
PMD a great potential for high-throughput studies in areas such
as cell culture or biochemistry. One can envision integrated
methods where numerous compounds could be simultaneously
tested in a range of concentrations and combinations in a single
experiment, significantly reducing the cost and time necessary forFig. 4 Software implementation of active mixing and micro-formulation. (a)
Opening a series of core valves creates a ring; actuating them repeatedly
(b) Micrographs showing a 12-node ring partially loaded with dye before an
4-node rings. This combination of mixing steps results in three different dye
1616 | Lab Chip, 2011, 11, 1612–1619such studies. Furthermore, creating complex feedback dynamics
with machine learning algorithms would allow a computer to
dynamically adjust the concentrations or compound combina-
tions during a screen, or even optimize the entire microfluidic
layout during the screening process.3.4. Cell culture
Cell culture is one of the most appealing applications of micro-
fluidics. The match between the dimensions of microfluidic
channels and a wide variety of cell types combined with high-
throughput and compatibility with light microscopy has made
miniaturized cell culture a major focus in the field. A number of
specialized devices have been developed to culture bacteria,9,12
yeast7,10 and mammalian cells.8,11,32 To show the potential of our
PMD for cell culture we implemented a multiplexed yeast culture
experiment. We loaded two yeast strains into 8 independentSchematic of the equivalent channels for the 12- and 4-node ring mixers.
generates peristaltic flow that homogenizes its contents (Video S3†).
d after mixing. (c) Micrographs showing 3 sequential mixing steps using
concentrations. Scale bar is 500 mm.
This journal is ª The Royal Society of Chemistry 2011
Fig. 5 (a) Active mixing in a 12-node ring using an increasing number of valves for peristaltic pumping. Mixing time increases as the number of valves
decreases. The mixing time required for the fastest pump (6 valves) is approximately 150 s. (b) Active mixing in a 4-node ring using four valves for
pumping. Mixing curves measured at the same point in the ring while loading either the top or bottom row show a 90 phase shift. Mixing is achieved in
approximately 30 s. (c–d) On-chip parallel micro-formulation. Three different dilutions of Fe(SCN)3 are prepared in separate 4-node ring mixers by
loading an increasing number of nodes with an initial solution (c) before homogenizing them (d). (e) Absorbance values extracted from the micrographs
for each final concentration agree with Lambert–Beer’s law. Each point represents the average of four measurements and the error bars show one
standard deviation.
Fig. 6 Cell culture in a software-programmable device. (a) Schematic of
the equivalent loading device implemented for cell trapping. (b) Micro-
graph of a seeded chamber (left) and a chamber being loaded (right).
Flowing a yeast suspension through a partially closed valve allows cell
trapping and control of seeding density (Video S5†). (c) Schematic of the
equivalent cell culture device. Micrographs of (d) a chamber after seeding
with wild type yeast and (e) after 12 h of culture. Scale bars are 100 mm.
This journal is ª The Royal Society of Chemistry 2011
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View Onlinegrowth chambers and grew them for 9 h in standard conditions.
We then switched the growth condition in 4 of the 8 chambers,
effectively performing 4 independent cell culture experiments in
duplicate.
We conceptually implemented two microfluidic devices, one
for cell loading and a second for cell culture. The loading chip
allowed independent addressing of the 8 growth chambers using
a path that could be partially closed using a core valve as a sieve
(Fig. 6a).33 To load cells to the desired density, a cell suspension
was flowed through the sieve trapping cells in the growth
chamber (Fig. 6b, Fig. S3a, Video S5†).
During culture, we needed to ensure correct compartmentali-
zation of the cell chambers while maintaining stable media
compositions over extended periods of time. To enable com-
partmentalized perfusion we implemented perfusion channels in
addition to growth chambers (Fig. 6c, Fig. S3b–c†). The culture
protocol consisted of two alternating steps: exchanging the
medium in the perfusion channels while the culture chambers
were closed; and allowing diffusion between culture and perfu-
sion chambers while preventing cross-talk with adjacent culture
chambers. Since there were two separate conditions on the
device, these alternating steps were performed simultaneously:
while one section was replenished the other was perfused and
vice versa (Fig. S3b–c†). The period of the cycle was one minute,
which ensured efficient medium replenishment as well as suffi-
cient diffusion of nutrients between perfusion channels and
culture chambers.Lab Chip, 2011, 11, 1612–1619 | 1617
Fig. 7 Quantification of yeast induction on chip. Two strains of yeast
were cultured in duplicate at two different conditions within the device.
Wild type yeast remains non-fluorescent under both inducing and non-
inducing conditions. A mutant expressing m-Cherry under the control of
the pho5 promoter increases its fluorescence upon induction. (inset)
Fluorescence micrographs of the chambers populated by the pho-5 strain
under both culture conditions showing the final levels of fluorescence.
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View OnlineCells were cultured in standard conditions for 9 h before
induction (Fig. 6d–e, Video S6†). Following the initial growth
period two chambers of each strain were induced by culturing
them in the absence of inorganic phosphate while the remaining
chambers continued under the original condition (Fig. 6c). We
used wild type yeast as a control and a mutant strain expressing
mCherry under the control of the pho5 promoter, which is
induced in the absence of inorganic phosphate.34 Fluorescence
imaging shows a considerable increase in fluorescence upon
induction (Fig. 7). In this experiment, we cultured each strain in
duplicate under inducing and non-inducing conditions,
accounting for a total of 8 simultaneous experiments. These
results show the potential of PMDs for performing exceedingly
complex methods such as parallel, automated cell culturing
under changing conditions.4. Conclusions
We have developed a highly-integrated PMD applicable to
a wide range of tasks. We have shown that our PMD can quickly
and accurately perform low- and high-level functions such as
automated addressing of the network nodes to generate
a display, as well as fluid metering and active mixing of
compounds. Biological applications such as immunoassays and
cell culturing were also successfully implemented. None of these
applications required the modification of the microfluidic device
hardware, but instead were fully implemented by software.
Our PMD features 64 individually addressable nodes
controlled by 15 external inputs. The number of controlled valves
increases exponentially with the number of inputs because of
multiplexing. The limitations in increasing the number of nodes
therefore stem exclusively from limitations related to the physical1618 | Lab Chip, 2011, 11, 1612–1619layout of channels and valves and their space requirements. We
foresee that the current layer structure could accommodate as
many as 256 nodes with only minor modifications of the routing
paths. Reducing the dimensions of vias and routing channels and
dividing these between multiple layers could further increase the
number of nodes.
The node geometry and connectivity described here are rela-
tively simple. Different node shapes and connectivities could be
optimized for various applications while maintaining the same
off-chip control hardware and software. Combining the flexi-
bility of the PMD with a number of dedicated devices could help
address specific applications while maintaining the benefits of
simplicity and low cost for the end-user. Indeed, hybrid devices
containing a PMD core supported by purpose built device
sections may combine the advantages of both platform concepts.
Eliminating the need to physically redesign devices will dras-
tically reduce the development time and cost of new microfluidic
applications. Moreover, using PMDs will enhance dissemination
of microfluidic technologies by eliminating the need for technical
knowledge of microfluidic device design and fabrication, and
allow researchers to quickly implement and debug their devices.
Just as with computers, generating general-purpose machines
and simplifying their use through software abstraction will
significantly increase the pervasiveness of microfluidic devices.
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